Simplify Logo

Full-Time

Vice President

Regulatory Affairs

Confirmed live in the last 24 hours

Insitro

Insitro

201-500 employees

Machine learning for drug discovery efficiency

AI & Machine Learning
Biotechnology

Compensation Overview

$295k - $335kAnnually

+ Annual Performance Bonus + Equity Incentive Plan

Senior

San Bruno, CA, USA

Onsite 3 days per week or hybrid (~1 week per month) in South San Francisco office.

Category
Public Health
Biology & Biotech
Requirements
  • Advanced degree in life sciences, technology, chemistry or related discipline, with specialized (e.g., M.S.) degree in regulatory science, or equivalent practical experience.
  • 10+ years of experience in regulatory affairs in biotechnology and/or pharmaceutical industries, directly as regulatory lead and in a leadership role to deliver therapeutic(s) and diagnostic biomarker(s) in our key therapeutic areas (metabolic disease, neurology/neurodegeneration, oncology) to the clinic from FIH through proof-of-concept to NDA/BLA submission.
  • Exposure to regulatory approvals involving computationally-enabled tools or biomarkers, with exposure to AI methods, is very nice to have.
  • Demonstrated understanding of regulations and guidelines governing drug, diagnostic, and device development, good clinical practice, clinical trial design and execution, the patient journey, clinical pharmacology, biostatistics, clinical operations, application of computation to drug development.
  • Capable of communicating and collaborating with people of diverse backgrounds and job functions, with a demonstrated a track record of collaborating with diverse stakeholders, including other clinical, translational, computational, and life scientists.
  • Strong interpersonal skills that motivate others to excel and achieve their very best.
Responsibilities
  • Build and lead the entire regulatory function across neurology/neurodegeneration, metabolic disease, oncology, and diagnostics. This will include diverse therapeutic modalities (e.g., small molecules, biologics, oligonucleotides) and novel laboratory and digital biomarkers, developed internally and in-licensed; all development stages (focus is IND/CTA through clinical proof-of-concept); diverse regulatory pathways; and regulatory elements of key drug development functions (e.g, clinical, chemistry, biologics, and device manufacturing controls, nonclinical).
  • Design and oversee innovative regulatory strategies to enable objective, data-driven go-no-go decisions efficiently and shorten the development cycle in the face of an evolving regulatory landscape.
  • Serve as global regulatory lead for the initial clinical-stage asset(s); over time, build and manage a focused, effective team of global regulatory leads to match our growing pipeline.
  • Be accountable for end-to-end global regulatory strategy, good clinical practice, and adherence to regulatory standards. This includes identification and mitigation of regulatory risks, creation, review, assembly, and submission of regulatory documents at all stages of development, and oversight of engagements with global health authorities and ethics committees.
  • Influence emerging regulatory policy for artificial intelligence and machine learning through original publications, presentations, and stakeholder engagement.
  • Interpret regulatory requirements for project and executive teams, board of directors, and scientific advisory board.

Insitro focuses on drug discovery and development in the pharmaceutical research sector. The company utilizes machine learning and biological tools to create predictive models that help identify successful paths for new medicines earlier in the process. This method aims to minimize the costly failures that often occur in pharmaceutical R&D. Insitro's team, which includes scientists, engineers, and drug hunters, collaborates to generate and analyze data to enhance the development of future drugs. Unlike traditional methods that rely heavily on intuition, Insitro's approach is data-driven and seeks to avoid unproductive routes in drug discovery. The company primarily serves pharmaceutical companies, healthcare providers, and research institutions looking for more effective drug development strategies. Insitro's goal is to improve the efficiency and success rate of bringing new medicines to market.

Company Stage

Series C

Total Funding

$825.4M

Headquarters

San Francisco, California

Founded

2018

Growth & Insights
Headcount

6 month growth

12%

1 year growth

20%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • With over $600 million in venture capital funding, Insitro is well-positioned for sustained growth and innovation in the pharmaceutical R&D sector.
  • The appointment of high-caliber professionals like Emily Fox and Philip Tagari strengthens Insitro's capabilities in AI-driven drug discovery and development.
  • Insitro's partnerships and board appointments, such as Amy Abernethy, indicate strong industry recognition and potential for impactful collaborations.

What critics are saying

  • The competitive landscape in AI-driven drug discovery is intense, with well-funded competitors like Xaira Therapeutics posing significant challenges.
  • Ethical and social justice issues related to AI in drug development, such as data privacy and diversity in clinical trials, could pose regulatory and reputational risks.

What makes Insitro unique

  • Insitro integrates machine learning with modern biological tools to create predictive models, setting it apart from traditional pharmaceutical R&D approaches.
  • The company's focus on data-driven insights and predictive modeling aims to reduce the high failure rates in drug discovery, a significant pain point in the industry.
  • Insitro's leadership team, including experts like Emily Fox and Philip Tagari, brings unparalleled expertise in AI, machine learning, and drug development, enhancing its competitive edge.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Excellent medical, dental, and vision coverage

Excellent mental health and well-being support

Open vacation policy

Access to free onsite baristas & cafe with daily lunch and breakfast

Access to free onsite fitness center

Commuter benefits

Paid parental leave

Competitive pay and 401(k) matching

Flexible work schedule (on site and remote)